127 related articles for article (PubMed ID: 24154702)
1. Anti-laminin γ1 pemphigoid accompanied by autoantibodies to laminin α3 and γ2 subunits of laminin-332.
Kamata M; Fujita H; Hamanaka T; Takahashi K; Koga H; Hashimoto T; Sato S
JAMA Dermatol; 2013 Dec; 149(12):1437-9. PubMed ID: 24154702
[No Abstract] [Full Text] [Related]
2. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
[No Abstract] [Full Text] [Related]
3. Pemphigoid without mucosal involvement showing autoantibodies against laminin-332 γ2 subunit.
Endo Y; Kato M; Kitoh A; Kore-Eda S; Fukuda S; Hashimoto T; Toda K; Miyachi Y; Utani A
Br J Dermatol; 2010 Nov; 163(5):1120-2. PubMed ID: 20586779
[No Abstract] [Full Text] [Related]
4. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
5. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
7. Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332.
Kikuchi K; Natsuga K; Shinkuma S; Nishie W; Kajita S; Sato H; Shimizu H
J Am Acad Dermatol; 2011 Oct; 65(4):878-880. PubMed ID: 21920249
[No Abstract] [Full Text] [Related]
8. Ex vivo pathogenicity of anti-laminin γ1 autoantibodies.
Florea F; Bernards C; Caproni M; Kleindienst J; Hashimoto T; Koch M; Sitaru C
Am J Pathol; 2014 Feb; 184(2):494-506. PubMed ID: 24300951
[TBL] [Abstract][Full Text] [Related]
9. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
[No Abstract] [Full Text] [Related]
10. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
[TBL] [Abstract][Full Text] [Related]
11. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid with IgG autoantibodies to the α3 subunit of laminin 332 associated with psoriasis vulgaris.
Ohashi M; Takagi H; Mizutani Y; Seishima M; Koga H; Hashimoto T
Eur J Dermatol; 2017 Jun; 27(3):306-307. PubMed ID: 28468743
[No Abstract] [Full Text] [Related]
13. Pemphigoid with autoantibodies to all laminin 332 subunits and BP230 developing vesicles within psoriatic plaques.
Ohata C; Mori Y; Tokita T; Koga H; Ohyama B; Sogame R; Hamada T; Ishii N; Furumura M; Hashimoto T
Eur J Dermatol; 2012; 22(6):812-3. PubMed ID: 23174568
[No Abstract] [Full Text] [Related]
14. Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Kayaba H; Sawamura D
J Dermatol; 2020 Jan; 47(1):e25-e26. PubMed ID: 31646656
[No Abstract] [Full Text] [Related]
15. Concurrence of autoantibodies to both laminin γ1 and γ2 subunits in a patient with kidney rejection response.
Mitate E; Kawano S; Nakao Y; Goto Y; Kobayashi I; Onozawa K; Hashimoto T; Nakamura S
Acta Derm Venereol; 2013 Jan; 93(1):114-5. PubMed ID: 22735827
[No Abstract] [Full Text] [Related]
16. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
17. Anti-p200/laminin γ1 pemphigoid associated with metastatic oesophageal cancer.
Goetze S; Dumke AK; Zillikens D; Hipler UC; Elsner P
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):e219-e221. PubMed ID: 27684497
[No Abstract] [Full Text] [Related]
18. Anti-laminin 5 pemphigoid: a case report of a benign cutaneous confined non-cicatricial variant.
Magro CM; Wu R
Int J Dermatol; 2012 Jan; 51(1):79-85. PubMed ID: 21790553
[No Abstract] [Full Text] [Related]
19. Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332.
Jedlickova H; Niedermeier A; Zgažarová S; Hertl M
Dermatology; 2011; 222(3):193-5. PubMed ID: 21228551
[No Abstract] [Full Text] [Related]
20. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
